Endoscopic Ultrasound Market
By Product Type;
Endoscope, Ultrasound Probe, Needle, Accessories and Ultrasonic ProcessorsBy Application;
Gastrointestinal Cancer, Lung Cancer, Pancreaticobiliary Disease and OthersBy End Use;
Hospitals, Ambulatory Surgical Centers and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Endoscopic Ultrasound Market Overview
Endoscopic Ultrasound Market (USD Million)
Endoscopic Ultrasound Market was valued at USD 1,003.23 million in the year 2024. The size of this market is expected to increase to USD 1,488.68 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.8%.
Endoscopic Ultrasound Market
*Market size in USD million
CAGR 5.8 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 5.8 % |
| Market Size (2024) | USD 1,003.23 Million |
| Market Size (2031) | USD 1,488.68 Million |
| Market Concentration | Medium |
| Report Pages | 335 |
Major Players
- B. Braun
- Boston Scientific Corporation
- Conmed Corporation
- Cook Medical
- Ethicon
- Fujifilm Corporation
- Medi-Globe Corporation
- PENTAX Medical
- Olympus Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Endoscopic Ultrasound Market
Fragmented - Highly competitive market without dominant players
Endoscopic Ultrasound Market is expanding rapidly as clinicians increasingly use internal imaging solutions for gastrointestinal diagnostics. Adoption has grown by over 35%, driven by the need for accurate assessments in oncology and pancreatic disease. This wave of strategic expansion highlights EUS as an indispensable tool in specialist care.
Advanced Probe Technology Driving Uptake
Innovations in high-frequency probes, tissue elasticity analysis, and needle guidance systems are pushing demand upward by 38%. These technological advancements improve diagnostic yield and reduce repeat procedures. The resulting push for innovation is elevating clinical standards and supporting ongoing market growth.
Collaborative Training Enhances Device Use
Approximately 30% of producers are engaging in partnerships with clinical centers and training programs to accelerate EUS adoption. These collaborations ensure better operator proficiency, cohesive training, and optimized device deployment. Such integrated product strategies support long-term market expansion and improved care pathways.
AI and Digital Integration Setting Future Standards
Nearly 42% of EUS systems are incorporating AI-enhanced imaging, real-time data analytics, and digital workflows. These technological advancements offer automatic interpretation, case reporting, and quality assurance. Such digital transformation is reinforcing the future outlook and enabling scalable expansion in precision diagnostics.
Endoscopic Ultrasound Market Key Takeaways
-
Rising prevalence of gastrointestinal and pulmonary cancers is accelerating the adoption of endoscopic ultrasound (EUS) as both a diagnostic and interventional tool.
-
Advancements in high-resolution imaging, elastography, contrast-enhanced EUS, and AI integration are expanding its role from diagnostics toward therapeutic procedures.
-
Endoscope systems represent the largest share of EUS product revenues, while needles and imaging platforms are showing the fastest growth trajectory.
-
Hospitals remain the leading end-use segment, though ambulatory surgical centers are gaining traction due to a shift toward minimally invasive, outpatient procedures.
-
North America continues to lead the market, while Asia-Pacific is emerging as the fastest-growing region driven by expanding healthcare infrastructure and higher diagnostic awareness.
-
Challenges such as high equipment costs, shortage of skilled professionals, and stringent regulatory approvals still restrain market penetration in developing economies.
-
Future growth depends on training programs, bundled device offerings, and integration of EUS systems that support both diagnostic and therapeutic workflows.
Endoscopic Ultrasound Market Recent Developments
-
In May 2024, a medical device manufacturer released a next-generation endoscopic ultrasound (EUS) platform with improved imaging resolution and real-time tissue characterization for GI diagnostics.
-
In January 2023, a healthcare technology firm acquired an endoscopy imaging startup to expand its EUS systems portfolio and strengthen its position in the minimally invasive diagnostics market.
Endoscopic Ultrasound Market, Segmentation Analysis
In this report, Endoscopic Ultrasound Market has been segmented by Product Type, Application, End Use, and Geography to provide a comprehensive understanding of market dynamics.
Endoscopic Ultrasound Market, Segmentation by Product Type
Product Type segmentation identifies the various components used in endoscopic ultrasound systems, impacting functionality, clinical use, and demand in healthcare settings.
Endoscope
Endoscopes are the core component of endoscopic ultrasound systems, used for visualizing internal organs and guiding ultrasound probes. Manufacturers focus on improving flexibility, visual clarity, and ease of use to enhance clinical outcomes.
Ultrasound Probe
Ultrasound probes provide high-resolution imaging and are essential for delivering accurate diagnostic results. Advances in probe sensitivity and image resolution are critical to enhancing the effectiveness of endoscopic ultrasound procedures.
Needle
Needles are used for tissue sampling and biopsy during endoscopic ultrasound procedures. They are designed for precision, minimal invasiveness, and ease of integration with ultrasound systems.
Accessories
Accessories include guidewires, injectors, and other devices that support the endoscopic ultrasound procedure by improving accessibility, precision, and patient comfort.
Ultrasonic Processors
Ultrasonic processors are essential for signal processing, converting ultrasound data into usable images. They play a key role in enhancing image quality and speed during endoscopic ultrasound procedures.
Endoscopic Ultrasound Market, Segmentation by Application
Application segmentation identifies the various clinical conditions where endoscopic ultrasound is used, highlighting its role in diagnosis and treatment.
Gastrointestinal Cancer
Endoscopic ultrasound is widely used in the diagnosis and staging of gastrointestinal cancers, providing accurate information about tumor size, location, and spread for treatment planning.
Lung Cancer
Endoscopic ultrasound is increasingly used in the diagnosis and staging of lung cancer, enabling precise lymph node biopsy and assessment of tumor invasiveness to guide therapeutic decisions.
Pancreaticobiliary Disease
Endoscopic ultrasound is an essential tool for diagnosing and managing pancreaticobiliary diseases, offering high-resolution imaging for detecting pancreatic cysts, tumors, and biliary obstructions.
Others
This category includes a variety of other applications, such as assessing gastroesophageal reflux disease (GERD), chronic pancreatitis, and other gastrointestinal conditions that benefit from the precision of endoscopic ultrasound.
Endoscopic Ultrasound Market, Segmentation by End Use
End‑use segmentation identifies the healthcare settings where endoscopic ultrasound systems are employed, reflecting market adoption based on clinical demand and infrastructure.
Hospitals
Hospitals, particularly those with specialized oncology, gastroenterology, and pulmonology departments, are the primary end-users of endoscopic ultrasound systems due to their broad patient base and advanced clinical needs.
Ambulatory Surgical Centers
Ambulatory surgical centers (ASCs) use endoscopic ultrasound systems for outpatient procedures, offering efficient, cost-effective diagnostics and treatments with minimal patient recovery time.
Others
This category includes smaller clinics, private practices, and diagnostic centers that may use endoscopic ultrasound systems for specific conditions or as part of a broader diagnostic toolkit.
Endoscopic Ultrasound Market, Segmentation by Geography
In this report, Endoscopic Ultrasound Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
North America
North America leads the market due to its advanced healthcare systems, high adoption rates of endoscopic ultrasound in hospitals and specialized centers, and increasing demand for minimally invasive diagnostic tools.
Europe
Europe demonstrates steady growth, with strong healthcare infrastructure, increasing adoption of advanced diagnostic tools, and rising cancer cases contributing to demand for endoscopic ultrasound systems.
Asia Pacific
Asia Pacific is expected to witness rapid growth, supported by improving healthcare access, rising healthcare investments, and increasing prevalence of gastrointestinal diseases and cancer.
Middle East & Africa
The Middle East & Africa region is showing increasing adoption of endoscopic ultrasound due to improving healthcare infrastructure and rising awareness of early-stage disease detection.
Latin America
Latin America is gradually increasing its adoption of endoscopic ultrasound systems due to improving healthcare access, higher cancer awareness, and expanding diagnostic facilities in both public and private sectors.
Endoscopic Ultrasound Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Endoscopic Ultrasound Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising gastrointestinal disorder cases
- Improved endoscopic ultrasound technology
- Aging population driving chronic disease demand
-
Specialized EUS centers' growth - The growth of specialized Endoscopic Ultrasound (EUS) centers reflects a notable trend within the healthcare landscape, showcasing a dedicated focus towards enhancing diagnostic and therapeutic capabilities. These centers, equipped with state-of-the-art technology and staffed by specialized professionals, cater to the increasing demand for precise gastrointestinal examinations and interventions.
They serve as hubs of excellence, offering comprehensive services ranging from routine screenings to complex procedures. The establishment of such centers not only signifies a commitment to elevating patient care standards but also fosters collaboration and knowledge-sharing among medical professionals, ultimately driving advancements in EUS techniques and outcomes.
Restraints
- Rural healthcare infrastructure gaps
- Procedure complications and risks
-
Strict EUS device regulations - Strict regulations governing Endoscopic Ultrasound (EUS) devices play a crucial role in ensuring patient safety and maintaining quality standards within the healthcare industry. These regulations, enforced by regulatory bodies worldwide, mandate rigorous testing, evaluation, and approval processes for EUS equipment before they can be marketed and utilized clinically.
By establishing stringent criteria for device design, manufacturing, and performance, these regulations aim to mitigate potential risks and uphold the reliability and effectiveness of EUS procedures. While compliance with these regulations may pose challenges for manufacturers, they ultimately contribute to fostering trust and confidence among healthcare providers and patients in the safety and efficacy of EUS technologies.
Opportunities
- Healthcare expansion in underserved region
- Demand for personalized medicine and EUS
- Diversified EUS applications
-
Emphasis on preventive healthcare and early detection - There is a growing emphasis on preventive healthcare and early detection strategies, with Endoscopic Ultrasound (EUS) playing a pivotal role in these efforts. Recognizing the significance of early diagnosis in improving treatment outcomes and reducing disease burden, healthcare systems and providers are increasingly integrating EUS into preventive care protocols.
EUS facilitates the early detection of various gastrointestinal malignancies, including pancreatic and esophageal cancers, enabling timely intervention and improved patient prognosis. By promoting proactive screening initiatives and leveraging the diagnostic precision of EUS, healthcare stakeholders aim to shift towards a preventive healthcare paradigm focused on identifying and addressing health risks at the earliest stages, thereby improving population health outcomes and reducing healthcare costs in the long run.
Endoscopic Ultrasound Market Competitive Landscape Analysis
Endoscopic Ultrasound Market is defined by strong competition, with nearly 65% controlled by leading medical device manufacturers. Established firms emphasize advanced strategies in product development and clinical support, while emerging players focus on specialized applications. Consolidation through merger, joint collaboration, and strategic partnerships continues to shape the sector, driving consistent innovation and sustaining measurable growth across healthcare systems.
Market Structure and Concentration
The industry demonstrates moderately high concentration, with top-tier companies holding around 60% of the market. Their dominance is reinforced by long-term partnerships with hospitals and research institutions. Mid-level firms are applying agile strategies to expand service offerings. This balance highlights steady expansion while supporting competitive growth across diagnostic and therapeutic endoscopic ultrasound applications.
Brand and Channel Strategies
More than 55% of product distribution occurs through direct hospital contracts and authorized distributors. Leading manufacturers invest in strong branding and diverse channel strategies to extend market reach. Strategic partnerships with healthcare providers strengthen trust, while coordinated collaboration efforts enhance after-sales support. These approaches secure long-term growth and reinforce competitive standing across clinical settings.
Innovation Drivers and Technological Advancements
Around 70% of recent product developments stem from innovation in imaging resolution, automation, and minimally invasive procedures. Companies prioritize advanced technological advancements to improve diagnostic accuracy and therapeutic applications. Strategic collaboration with research institutes accelerates innovation cycles. These integrated strategies drive long-term growth while ensuring competitive differentiation in the evolving endoscopic ultrasound landscape.
Regional Momentum and Expansion
North America and Europe account for nearly 65% of market activity, driven by advanced healthcare infrastructure and high adoption rates. Asia-Pacific is experiencing accelerated expansion through distributor partnerships and localized production. Cross-regional collaboration strengthens access to cutting-edge devices, reinforcing balanced growth and expanding the market’s presence across developed and emerging healthcare economies.
Future Outlook
Over 75% of stakeholders anticipate significant growth in the coming decade, supported by sustained innovation in minimally invasive technologies. Strategic merger initiatives and cross-industry collaboration will remain essential for expansion. Companies investing in advanced technological advancements are aligning strategies with clinical needs, shaping the long-term future outlook of the Endoscopic Ultrasound Market.
Key players in Endoscopic Ultrasound Market include :
- Olympus Corporation
- PENTAX Medical
- FUJIFILM Holdings Corporation
- Boston Scientific Corporation
- Medtronic
- Cook Medical
- CONMED Corporation
- Medi‑Globe GmbH
- Steris
- Esaote SpA
- SonoScape Medical Corp.
- Limaca Medical Ltd
- Hitachi Medical Systems
- Zhejiang Soudon Medical Technology Co., Ltd.
- Beijing Lepu Medical Technology
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Endoscopic Ultrasound Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Rising gastrointestinal disorder cases
- Improved endoscopic ultrasound technology
- Aging population driving chronic disease demand
- Specialized EUS centers' growth
- Restraints
- Rural healthcare infrastructure gaps
- Procedure complications and risks
- Strict EUS device regulations
- Opportunities
- Healthcare expansion in underserved region
- Demand for personalized medicine and EUS
- Diversified EUS applications
- Emphasis on preventive healthcare and early detection
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Endoscopic Ultrasound Market, By Product Type, 2021 - 2031 (USD Million)
- Endoscope
- Ultrasound Probe
- Needle
- Accessories
- Ultrasonic Processors
- Endoscopic Ultrasound Market, By Application, 2021 - 2031 (USD Million)
- Gastrointestinal Cancer
- Lung Cancer
- Pancreaticobiliary Disease
- Others
- Endoscopic Ultrasound Market, By End Use, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Endoscopic Ultrasound Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Endoscopic Ultrasound Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Olympus Corporation
- PENTAX Medical
- FUJIFILM Holdings Corporation
- Boston Scientific Corporation
- Medtronic
- Cook Medical
- CONMED Corporation
- Medi‑Globe GmbH
- Steris
- Esaote SpA
- SonoScape Medical Corp.
- Limaca Medical Ltd
- Hitachi Medical Systems
- Zhejiang Soudon Medical Technology Co., Ltd.
- Beijing Lepu Medical Technology
- Company Profiles
- Analyst Views
- Future Outlook of the Market

